- Home
- MLR vs QURE Comparison
MLR vs QURE Comparison
Compare MLR & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLR
- QURE
- Stock Information
- Founded
- MLR 1990
- QURE 1998
- Country
- MLR United States
- QURE Netherlands
- Employees
- MLR N/A
- QURE N/A
- Industry
- MLR Construction/Ag Equipment/Trucks
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- MLR Consumer Discretionary
- QURE Health Care
- Exchange
- MLR Nasdaq
- QURE Nasdaq
- Market Cap
- MLR 769.3M
- QURE 750.6M
- IPO Year
- MLR 1994
- QURE 2007
- Fundamental
- Price
- MLR $67.78
- QURE $15.76
- Analyst Decision
- MLR Strong Buy
- QURE Strong Buy
- Analyst Count
- MLR 1
- QURE 8
- Target Price
- MLR $82.00
- QURE $30.43
- AVG Volume (30 Days)
- MLR 85.1K
- QURE 4.5M
- Earning Date
- MLR 11-12-2024
- QURE 11-05-2024
- Dividend Yield
- MLR 1.12%
- QURE N/A
- EPS Growth
- MLR 35.81
- QURE N/A
- EPS
- MLR 6.02
- QURE N/A
- Revenue
- MLR $1,331,839,000.00
- QURE $28,587,000.00
- Revenue This Year
- MLR $16.10
- QURE $150.65
- Revenue Next Year
- MLR $6.72
- QURE N/A
- P/E Ratio
- MLR $11.26
- QURE N/A
- Revenue Growth
- MLR 22.98
- QURE N/A
- 52 Week Low
- MLR $38.33
- QURE $3.73
- 52 Week High
- MLR $78.25
- QURE $17.71
- Technical
- Relative Strength Index (RSI)
- MLR 38.82
- QURE 74.36
- Support Level
- MLR $71.24
- QURE $6.11
- Resistance Level
- MLR $72.80
- QURE $17.71
- Average True Range (ATR)
- MLR 1.99
- QURE 1.42
- MACD
- MLR -0.76
- QURE 0.91
- Stochastic Oscillator
- MLR 4.72
- QURE 83.50
About MLR Miller Industries Inc.
Miller Industries Inc is engaged in the manufacturing of vehicle towing and recovery equipment. The company produces wreckers, car carriers, and trailer bodies under the Century, Vulcan, Challenger, Holmes, Champion, Chevron, Eagle, Titan, Jige, and Boniface brands. The products are sold in North America, Canada, and Mexico through independent distributors.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.